Exact Mass: 263.0713
Exact Mass Matches: 263.0713
Found 20 metabolites which its exact mass value is equals to given mass value 263.0713
,
within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error
0.0002 dalton.
Gemcitabine
Gemcitabine is a nucleoside analog used as chemotherapy. It is marketed as Gemzar by Eli Lilly and Company. As with fluorouracil and other analogues of pyrimidines, the drug replaces one of the building blocks of nucleic acids, in this case cytidine, during DNA replication. The process arrests tumor growth, as new nucleosides cannot be attached to the faulty nucleoside, resulting in apoptosis (cellular suicide). L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BC - Pyrimidine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2150 - Ribonucleotide Reductase Inhibitor CONFIDENCE standard compound; EAWAG_UCHEM_ID 2603 CONFIDENCE standard compound; INTERNAL_ID 2106 D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Gemcitabine (LY 188011) is a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent. Gemcitabine inhibits DNA synthesis and repair, resulting in autophagyand apoptosis[1][2].
Difluorodeoxycytidine
Gemctitabine
2-(chloromethyl)-1-methyl-5-phenylmethoxypyridin-4-one
ethyl 5-chloro-2,8-dimethylquinoline-3-carboxylate
ethyl 6-chloro-2,8-dimethylquinoline-3-carboxylate
4-Chloro-6-ethylquinoline-3-carboxylic acid ethyl ester
Ethyl 4-chloro-5,7-dimethylquinoline-3-carboxylate
Ethyl 4-chloro-5,8-dimethylquinoline-3-carboxylate
ethyl 4-chloro-6,7-dimethylquinoline-3-carboxylate
Ethyl 4-chloro-7,8-dimethylquinoline-3-carboxylate
Clopirac
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
Ethyl 4-chloro-6,8-dimethylquinoline-3-carboxylate
1-(2-Hydroxyphenyl)-3-(pyridin-4-yl)propan-1-one HCl
4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-2-oxolanyl]-2-pyrimidinone
Gemcitabine
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01B - Antimetabolites > L01BC - Pyrimidine analogues C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2150 - Ribonucleotide Reductase Inhibitor D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Gemcitabine (LY 188011) is a pyrimidine nucleoside analog antimetabolite and an antineoplastic agent. Gemcitabine inhibits DNA synthesis and repair, resulting in autophagyand apoptosis[1][2].